RLG Redoubles Efforts to Inform Public About Dangers of Zoloft, in Light of Link Between SSRI Use During Pregnancy, Risk of Autism in Newborns
According to a July 4, 2011, piece in the New York Times, an article published in the Archives of General Psychiatry reported “an elevated risk of autism in children whose mothers took a popular type of antidepressant during the year before delivery.” These drugs, so-called SSRIs, include Prozac, Zoloft, Celexa, and Lexapro. According to the Times, “Dr. Joseph Coyle, the editor in chief of the psychiatry journal, called the [study] ‘[a] game changer….’”
Previous studies have linked Zoloft to numerous birth defects in children born to mothers who were taking the drug while pregnant. These include: clubbed foot; cleft lip/palate; delayed development; persistent pulmonary hypertension; gastrochisis; heart defects; skull defects; and brain/spinal cord defects. Moreover, Zoloft can cause premature birth or even miscarriage. And a child exposed to Zoloft in utero can experience withdrawal symptoms after birth.
The Rottenstein Law Group encourages online visitors to link to its sites from their own blogs and Web sites to spread information about defective medical products and dangerous drugs.
